☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
aquire
Sorrento to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies Targeting COVID-19 and Cancer
July 27, 2020
Alexion to Acquire Syntimmune for antibody therapeutics targeting the neonatal Fc receptor (FcRn)
September 27, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
